Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasms, Squamous Cell × Biological Products × 30 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Gastrointestinal 1

Conditions

Neoplasms, Squamous Cell 1 Neoplasms 1 Lung Neoplasms 1 Esophageal Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

pembrolizumab 1 Nivolumab 1 Injections 1 Erlotinib Hydrochloride 1 Docetaxel 1 Cisplatin 1 Cetuximab 1 Biological Products 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04908111 2026-04-06

A Trial of ChAdOx1 and MVA Vaccines Against MAGE-A3 and NY-ESO-1

Cancer Research UK

Phase 1/2 Suspended

GastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms, Lung Neoplasms, Neoplasms, Neoplasms, Squamous Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡